Clara Curiel, MD, Director of the Pigmented Lesion Clinic and the Multidisciplinary Cutaneous Oncology Program at the Skin Cancer Institute of Arizona Cancer Center and Assistant Professor of Dermatology at the University of Arizona College of Medicine, has been named to the new Levin Family Endowed Chair for Excellence in Cancer Research at the Cancer Center. The Chair was funded by a $1 million gift to the University of Arizona Foundation from Alan Levin, a patient of Dr. Curiel's, and his wife Janice.
Nevada Cancer Institute researchers Michael Gach, PhD, and Hong Sun, MD, PhD, have been awarded $50,000 grants from the Health Sciences Systems of the Nevada System of Higher Education Inter-institutional Biomedical Research Activities Fund. The grants are designed to support basic, behavioral, and clinical research in biomedical sciences with the broadest possible definition. Dr. Gach's proposal (submitted along with Steen Madsen, PhD, of the University of Nevada, Las Vegas) was “Macrophage-mediated Delivery of Nanoparticles for Photothermal Ablation of Malignant Gliomas;” Dr. Sun's (submitted with Patricia M. Berninsone, PhD, of the University of Nevada, Reno) was “Using C. elegans Embryonic Cell Culture System to Study Mechanisms of Signal Transduction by the DAF-2insulin/IGF-I-like Receptor.”
Sharmila Makhija, MD, has joined Emory University School of Medicine and the Emory Winship Cancer Institute as Director of Gynecologic Oncology. Dr. Makhija comes to Emory from the University of Alabama at Birmingham (UAB) where she served as Associate Professor of Gynecology/Oncology and Associate Scientist in the UAB Comprehensive Cancer Center.
Michele Pagano, MD, has been appointed Deputy Director of the NYU Cancer Institute at the NYU Langone Medical Center. Dr. Pagano, who is the May Ellen and Gerald Ritter Professor of Oncology in the Department of Pathology, has led the NYU Cancer Institute's Growth Control Program since 2000. As Deputy Director, he will work with members of the senior leadership team of the medical center to develop a unified agenda for cancer research and therapy and to speed the translation of laboratory findings into more effective approaches to cancer prevention and treatment.
William Pao, MD, PhD, and William Tansey, PhD, have joined the staff at Vanderbilt-Ingram Cancer Center. Dr. Pao joins as Associate Professor of Medicine in the Division of Hematology/Oncology, with secondary appointments in the Departments of Cancer Biology and Pathology. He has also been named Assistant Director of Personalized Cancer Medicine and an Ingram Associate Professor of Cancer Research. Dr. Pao's research focus will be defining clinically relevant molecular subsets of lung cancer.
Dr. Tansey joins as Professor of Cell and Developmental Biology and Co-Leader of the Genome Maintenance Program, as well as Ingram Professor of Cancer Research. His research will focus on the regulation of gene activity in normal and cancer cells.
© 2009 Lippincott Williams & Wilkins, Inc.
More on ONCOLOGY-TIMES.com...